FDA Inspection 1007309 — Prisma Health
The FDA completed an inspection of Prisma Health on Apr 13, 2017 in Greenville, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 13, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Greenville, SC (United States)